Live feed
Filing
SC 13G/A
SC 13G/A0001422848-18-000008·Capital Research Global Investors
Schedule 13G ownership disclosure
TEVA PHARMACEUTICAL INDS LTD
Security class unavailable · CUSIP: 881624209
Event date: 2018-01-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 121,617,748
- Percent of class
- 11.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001422848-18-000008
- Form type
- SC 13G/A
- Filer
- Capital Research Global Investors
- CIK
- CIK 1422848
- Filed
- Feb 09, 2018
- Reporting period
- Jan 31, 2018
- Description
- Schedule 13G beneficial ownership